PUBLISHER: iData Research Inc. | PRODUCT CODE: 1571027
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1571027
In 2023, the European market for orthopedic biomaterials was valued at over €554 million. This market is projected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching nearly €643 million by 2030. The full report on the European orthopedic biomaterials market includes bone graft substitutes (allografts, demineralized bone matrices (DBMs), and synthetic bone grafts), orthopedic growth factors, cell therapies (bone marrow aspirate concentrate and platelet-rich plasma), hyaluronic acid (HA) viscosupplementation (single-, two-, three-, and five-injection cycles), and orthopedic cartilage repair (osteochondral allografts, meniscal allografts, autologous chondrocyte implantation, and osteochondral autografts).
Key demographic trends continue to drive the European orthopedic biomaterials market. A notable factor is the rising incidence of osteoarthritis (OA) in the spine, particularly as the population ages, leading to an increasing number of spinal fusion procedures. With the aging population, driven by the retirement of the first wave of baby boomers starting in 2008, there has been a growing demand for treatments addressing arthritis and degenerative disc disease. This has led to an increased need for bone graft substitutes. Additionally, the prevalence of degenerative diseases is further accelerated by rising obesity rates, driving demand for orthopedic biomaterials and associated procedures. These trends are expected to propel market growth during the forecast period.
Fidia maintained its leadership position in the European orthopedic biomaterials market, bolstered by the strong performance of its HA viscosupplementation products, Hyalubrix(R) and Hyalgan(R).
Medtronic ranked as the second-largest player, largely due to its dominance in the orthopedic growth factor market with its INFUSE(TM) product.
Bioventus secured the third-largest market share, primarily as the leading distributor of DUROLANE(R), a single-injection treatment, across Europe.
TABLE of CONTENTS
List of Figures
List of Charts
executive summary
European Orthopedic Biomaterials Market Overview
Competitive Analysis
Emerging Markets and Technologies
Market Trends
Market Developments
Market Segmentation
Procedure Segmentation
Key Report Updates
Version History
research methodology
impact of covid-19 on THE European Orthopedic Biomaterials Market
Product Assessment
European Orthopedic Biomaterials Market Overview
Country Profiles
Procedure Numbers
orthopedic Bone Graft Substitute Market
ORthopedic Growth Factor Market
Orthopedic Cell Therapy Market
Hyaluronic Acid Viscosupplementation Market
Orthopedic Cartilage Repair Market
Abbreviations